Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Mannkind's Afrezza May Be Half As Effective As Current Injectable Insulins

+1 to chmith27

Just to add to the thread,though, I sold another 10% of my position, only due to the incessant hit pieces out there which I am certain will continue for the next six agonizing months.

I was pretty sure that the test results would be positive, but given the tepid response to the news, I decided it's time to lighten up a little.

Do I still believe in Afezza? You bet.

Will it still be a blockbuster? You bet.

Do I still believe in Al Mann? You bet.

Does any of this matter really matter in the end? No.

As long as there are more sellers than buyers, the stock will be under continued pressure until some BP steps up to the plate.

Share
New Message
Please login to post a reply